1. Home
  2. PW vs SXTP Comparison

PW vs SXTP Comparison

Compare PW & SXTP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PW

Power REIT (MD)

N/A

Current Price

$8.00

Market Cap

3.4M

Sector

Real Estate

ML Signal

N/A

Logo 60 Degrees Pharmaceuticals Inc.

SXTP

60 Degrees Pharmaceuticals Inc.

N/A

Current Price

$1.20

Market Cap

3.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PW
SXTP
Founded
1967
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4M
3.0M
IPO Year
2011
2023

Fundamental Metrics

Financial Performance
Metric
PW
SXTP
Price
$8.00
$1.20
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$14.10
AVG Volume (30 Days)
13.0K
69.3K
Earning Date
05-13-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
88.90
36.77
EPS
N/A
N/A
Revenue
$1,982,265.00
$1,005,471.00
Revenue This Year
N/A
$33.92
Revenue Next Year
N/A
$51.35
P/E Ratio
N/A
N/A
Revenue Growth
0.32
65.49
52 Week Low
$0.50
$0.34
52 Week High
$12.92
$8.62

Technical Indicators

Market Signals
Indicator
PW
SXTP
Relative Strength Index (RSI) 44.91 37.45
Support Level $7.25 $1.07
Resistance Level $11.62 $1.62
Average True Range (ATR) 0.52 0.13
MACD -0.07 -0.01
Stochastic Oscillator 36.41 20.63

Price Performance

Historical Comparison
PW
SXTP

About PW Power REIT (MD)

Power REIT is an internally-managed real estate investment trust that owns a portfolio of real estate assets related to transportation, energy infrastructure and Controlled Environment Agriculture in the United States. Its assets consisted of approximately 112 miles of railroad infrastructure and related real estate which is owned by its subsidiary, approximately 447 acres of fee simple land leased to a utility scale solar power generating project with an aggregate generating capacity of approximately 82 Megawatts and approximately 82 acres of land with approximately 357,000 square feet of CEA properties in the form of greenhouses. The company invested in greenhouses for state-licensed cannabis and food cultivation.

About SXTP 60 Degrees Pharmaceuticals Inc.

60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. Currently, company's pipeline under development covers development programs for vector-borne, fungal, and viral diseases utilizing three of the Company's future products: (i) new products that contain the Arakoda regimen of Tafenoquine; (ii) new products that contain Tafenoquine; and (iii) Celgosivir and/or botanical extracts from Australian Chestnut Trees.

Share on Social Networks: